1-1 of 1
Francois-Xavier Mahon, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Imatinib Mesylate Dose Escalation Improves Disease Response in Chronic-Phase Chronic Myeloid Leukaemia Patients after Cytogenetic or Molecular Suboptimal Responses to Standard Doses of Imatinib.

Delphine Rea, MDPhD, Gabriel Etienne, MD, Selim Corm, MD, Pascale Cony-Makhoul, MD, Martine Gardembas, MD, Francois-Xavier Mahon, MDPhD, Franck Nicolini, MDPhD
Journal: Blood
Blood (2007) 110 (11): 1052.
https://doi.org/10.1182/blood.V110.11.1052.1052
Published: 2007